Healthcare provider profile · identity verified

Michael Barry, M.D.

Family Practice · TUCSON, AZ · NPI 1376623991

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	800	215
Amlodipine Besylate	Amlodipine Besylate	465	124
Simvastatin	Simvastatin	379	86
Lisinopril	Lisinopril	360	99
Losartan Potassium	Losartan Potassium	339	90
Tamsulosin Hcl	Tamsulosin Hcl	305	70
Levothyroxine Sodium	Levothyroxine Sodium	273	64
Metoprolol Succinate	Metoprolol Succinate	256	61
Omeprazole	Omeprazole	247	67
Furosemide	Furosemide	234	62
Hydrochlorothiazide	Hydrochlorothiazide	214	65
Metformin Hcl Er	Metformin Hcl	212	60
Pantoprazole Sodium	Pantoprazole Sodium	208	68
Gabapentin	Gabapentin	203	53
Metformin Hcl	Metformin Hcl	192	48
Eliquis	Apixaban	164	33
Metoprolol Tartrate	Metoprolol Tartrate	158	43
Allopurinol	Allopurinol	157	40
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	146	39
Tramadol Hcl	Tramadol Hcl	133	33
Escitalopram Oxalate	Escitalopram Oxalate	128	27
Pravastatin Sodium	Pravastatin Sodium	123	33
Potassium Chloride	Potassium Chloride	114	27
Jardiance	Empagliflozin	113	26
Clopidogrel	Clopidogrel Bisulfate	98	30
Sertraline Hcl	Sertraline Hcl	96	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	90	18
Clonazepam	Clonazepam	88	11
Fluticasone Propionate	Fluticasone Propionate	82	31
Donepezil Hcl	Donepezil Hcl	80	15
Alendronate Sodium	Alendronate Sodium	77	18
Rosuvastatin Calcium	Rosuvastatin Calcium	77	21
Albuterol Sulfate Hfa	Albuterol Sulfate	74	38
Alprazolam	Alprazolam	73	21
Atenolol	Atenolol	71	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	69	17
Glipizide	Glipizide	60	16
Glimepiride	Glimepiride	59	20
Lorazepam	Lorazepam	58	16
Famotidine	Famotidine	55	17
Tizanidine Hcl	Tizanidine Hcl	55	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	54	15
Fentanyl	Fentanyl	51	suppressed
Trazodone Hcl	Trazodone Hcl	50	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	49	suppressed
Spironolactone	Spironolactone	49	17
Finasteride	Finasteride	48	12
Zolpidem Tartrate	Zolpidem Tartrate	47	11
Oxybutynin Chloride	Oxybutynin Chloride	45	12
Meloxicam	Meloxicam	44	20
Paroxetine Hcl	Paroxetine Hcl	43	suppressed
Prednisone	Prednisone	43	23
Duloxetine Hcl	Duloxetine Hcl	42	13
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Carvedilol	Carvedilol	41	12
Propranolol Hcl	Propranolol Hcl	40	suppressed
Pregabalin	Pregabalin	39	11
Doxazosin Mesylate	Doxazosin Mesylate	38	suppressed
Diazepam	Diazepam	34	suppressed
Lovastatin	Lovastatin	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Benazepril Hcl	Benazepril Hcl	32	suppressed
Propranolol Hcl Er	Propranolol Hcl	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Nystatin	Nystatin	29	14
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Glipizide Er	Glipizide	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	20
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Doxepin Hcl	Doxepin Hcl	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	20	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Valsartan	Valsartan	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Metolazone	Metolazone	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Azathioprine	Azathioprine	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	11
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Balsalazide Disodium	Balsalazide Disodium	12	suppressed
Colchicine	Colchicine	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error